FYERS
Home
/
Stocks
/
Profit Loss
/
RPG Life Sciences Profit & Loss

RPG Life Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
₹212 Cr₹196 Cr₹177 Cr₹180 Cr₹182 Cr₹169 Cr₹143 Cr₹173 Cr
₹4 Cr₹5 Cr₹12 Cr₹3 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr
₹216 Cr₹200 Cr₹189 Cr₹183 Cr₹186 Cr₹174 Cr₹148 Cr₹176 Cr
₹178 Cr₹158 Cr₹150 Cr₹146 Cr₹148 Cr₹139 Cr₹123 Cr₹129 Cr
₹45 Cr₹48 Cr₹45 Cr₹43 Cr₹44 Cr₹41 Cr₹31 Cr₹52 Cr
₹84 L₹63 L₹39 L₹25 L₹12 L₹13 L₹18 L₹12 L
₹37 Cr₹41 Cr₹40 Cr₹29 Cr₹49 Cr₹35 Cr₹135 Cr₹47 Cr
₹28 Cr₹31 Cr₹30 Cr₹22 Cr₹37 Cr₹26 Cr₹117 Cr₹35 Cr

Share Price Live Stats

Open (₹)2,587.70
Volume (₹)6,841.00
High (₹)2,591.00
Upper Circuit3,059.40
Low (₹)2,520.00
Lower Circuit2,039.60
Prev Close2,549.50
52W High (₹)3,127.80
Price2,525.00
52W Low (₹)1,733.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4214.31 Cr
Div. Yield (%)0.94
PE Ratio38.53
Debt to Equity0.03
Price to Book5.05
Book Value366.05
EPS (TTM)66.14
Face Value8.00
ROE (%)20.28

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
RPGLIFENSE
LTP
1W Low
1W High
Market cap (₹)
1769.9-7.8 (-0.44%)
1722
1855
4,24,202Cr
10064+284 (2.90%)
9621.50
10064
2,64,141Cr
4650+36.6 (0.79%)
4532
4675
1,74,402Cr
2323-82.5 (-3.43%)
2206.10
2441.90
1,26,811Cr
1240.6-4.9 (-0.39%)
1182
1254.20
1,23,685Cr
1368.3+16.3 (1.21%)
1336.70
1368.30
1,11,868Cr
1396.9+18 (1.31%)
1357
1396.90
1,11,650Cr
2475-17.8 (-0.71%)
2457.90
2528
1,02,196Cr
1694.5+13.1 (0.78%)
1647.20
1697.40
96,951Cr
2015.9+4.9 (0.24%)
1974
2033.80
91,301Cr
2525-50.7 (-1.97%)
2480
2849.60
4,214Cr

Key Highlights of RPG Life Sciences Ltd’s P&L

In 2026-03-31, RPG Life Sciences Ltd reported total revenue of ₹733.1Cr, compared with ₹667.76Cr in 2025-03-31, reflecting RPG Life Sciences Ltd turnover.

Depreciation was ₹21.48Cr and finance costs were ₹1.77Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹154.2Cr in 2026-03-31 as compared to ₹232.88Cr in 2025-03-31.

Net Profit (PAT) was ₹115.17Cr in 2026-03-31 compared with ₹183.24Cr in 2025-03-31.

Earnings per share (EPS) were ₹69.64 in 2026-03-31, compared with ₹110.80 in 2025-03-31.